The Effect of Mitapivat on Cerebral Perfusion and Oxygen Metabolism in Sickle Cell Disease
This study is investigating a drug called mitapivat for individuals living with sickle cell anaemia. The main goal is to understand how mitapivat influences blood flow and oxygen use in the brain. Researchers will use special MRI scans at 3 and 12 months to measure these changes. They're also looking at other health markers, including heart function, using different tests like echocardiograms. This research aims to see if mitapivat can help improve brain health and overall well-being for people with sickle cell anaemia, ultimately hoping to confirm if this treatment has a positive effect.
Överblick
Vad handlar denna studie om?
This study is a Phase III clinical trial, which means it's one of the final steps in testing a new medication before it can be made widely available. It's designed for people who have sickle cell anaemia, a condition that affects red blood cells and can sometimes lead to complications in different parts of the body, including the brain.
The main purpose of this research is to understand how a new medicine called mitapivat affects the brain. Specifically, scientists want to see how much blood flows to the brain and how well the brain uses oxygen. These are important measures because problems with blood flow and oxygen can sometimes lead to issues for people with sickle cell anaemia. They will use special types of MRI scans, which are safe and painless, to check these things at two points in time: after 3 months and again after 12 months of treatment.
Beyond just the brain, the study will also look at other important health indicators. For example, they'll check heart function using a test called an echocardiogram, which uses sound waves to create images of your heart. This comprehensive approach helps researchers get a full picture of how mitapivat might affect different body systems. The overall goal is to gather strong evidence to confirm if mitapivat is an effective and safe treatment that can make a positive difference for people with sickle cell anaemia.
Viktiga punkter
- This study is testing a new medicine called mitapivat for sickle cell anaemia.
- It will carefully check how the medicine affects blood flow and oxygen use in the brain.
- Special MRI scans and heart checks will be done at 3 and 12 months.
- The study lasts for about 12 months.
- It aims to find out if mitapivat can help improve health for people with sickle cell anaemia.
- Participation is for adults aged 18 and over.
Vem kan vara berättigad?
This study is looking for volunteers who have sickle cell anaemia.
You must be an adult aged 18 years or older to take part. There is no upper age limit for joining this particular study.
Both men and women are welcome to participate in this research.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Do you have sickle cell anaemia?
- Är du 18 år eller äldre?
- Are you able to attend appointments for up to 12 months?
- Are you willing to have MRI scans and heart checks?
Vad innebär deltagande?
If you decide to join this study, you would be taking a medicine called mitapivat. Throughout your participation, you would have several clinic visits over 12 months. During these visits, you will have special MRI scans to check blood flow and oxygen use in your brain. You will also have heart checks using an echocardiogram. These assessments will happen at 3 months and again at 12 months to see how you respond to the treatment over time. The total duration of your active involvement in the study would be about 12 months, with follow-up appointments scheduled during this period.
Potentiella risker och fördelar
Platser (1)
- —ObekräftadNederländerna
Vanliga frågor
What is mitapivat?
Mitapivat is a medicine being studied to see if it can help people with sickle cell anaemia.
What is sickle cell anaemia?
Sickle cell anaemia is a blood disorder that affects red blood cells, which carry oxygen around the body.
Vad är en MR-skanning?
An MRI scan is a safe, painless test that uses strong magnets and radio waves to create detailed pictures inside your body, in this case, your brain.
Hur länge kommer jag att vara med i studien?
If you join, you will be in the study for about 12 months, with check-ups at 3 and 12 months.
Kan jag lämna studien om jag ändrar mig?
Yes, you can leave the study at any time, for any reason, and it will not affect your usual medical care.
Hur du får reda på mer
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.